MASTER OF SCIENCE IN BIOCHEMICAL ENGINEERING
Enhance your skill set, increase your earning potential, and learn about new technology and modeling approaches for biopharmaceutical production and development with a graduate degree in biochemical engineering.
Villanova’s Master's in Biochemical Engineering program provides real-world knowledge for practical application covering hot-button topics including biopharmaceutical design and biomaterials and drug delivery. This degree exposes students to upstream and downstream bioprocess fundamentals and provides the tools to design and optimize pharmaceutical facilities, processes and products, using state-of-the-art analysis and technology.
Our Community
Pursuing an engineering master's degree at Villanova is to become part of a close-knit, scholarly community. Professors are highly available and engaged in their students' success.
Master's in Biochemical Engineering:
- 46% female
- 67% part-time
- Average age: 26
- Total enrollment: 24
Flexible Options
Classes are conveniently held in the evenings to allow you to successfully balance work and family while earning your degree. You can participate in class on campus, in real-time (synchronously) via our E-Learning program, or on your own schedule through recorded materials and lectures. Our graduate programs are unique in that you can combine online and on campus options, attending class or participating remotely depending upon your availability and preference. You can also complete your biochemical engineering graduate degree entirely online. Learn more about the opportunities of E-Learning.
Successful Outcomes
Villanova’s Biochemical Engineering graduate program alumni work for some of the largest pharmaceutical companies in the nation, including:
Bristol-Myers Squibb
Eli Lilly and Company
GlaxoSmithKline
Johnson & Johnson
Janssen Pharmaceuticals
Merck
RESEARCH
Ongoing research areas for faculty in Biochemical Engineering:
- Alternating tangential flow system optimization
- Thin film delivery of anti-inflammatory agents
- Nano/Micro particle design for drug delivery
- Design and delivery of gene therapy vehicles
- Characterization of thin film nanomaterials
- T-cell activation and production
- Optimization of microbioreactors
- CHO cell metabolism
- Pathogens in biofilms
- Development of blood substitutes
WHERE ARE THEY NOW?
Luke Badalaty ’12 ChE, ’15 MSBChE
Title: Associate Director, Project Management
Company: Kyverna Therapeutics
Colleen Clark, PhD, ’12 ChE, ’14 MSBChE
Title: Manager, Strategic Options and Assessment
Company: Bristol-Myers Squibb
Matthew Tucker ’17 MSBChE
Title: Vaccine Process Development
Company: Takeda